Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 4Triple Negative Breast Neoplasms 3Breast Neoplasms 2Recurrence 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cancer Recurrent 1Neoplasm Metastasis 1Melanoma 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1

Interventions

Tamoxifen 12Early Intervention, Educational 7Methods 6Practice Guidelines as Topic 5Neoadjuvant Therapy 5Immunohistochemistry 5Counseling 5Chemotherapy, Adjuvant 5Anastrozole 5Standard of Care 4Specimen Handling 4Radiotherapy 4Psychiatric Rehabilitation 4Mastectomy, Segmental 4Mass Spectrometry 4Letrozole 4Educational Status 4Behavior Therapy 4Gene Expression Profiling 3Biopsy 3exemestane 2Telemedicine 2Taxes 2Surveys and Questionnaires 2Soybean Proteins 2Simvastatin 2Sentinel Lymph Node Biopsy 2Radiosurgery 2Radiation Dose Hypofractionation 2Radiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Carcinoma In Situ × poly(I).poly(c12,U) × Clear all
NCT04081389 2023-09-11

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Roswell Park Cancer Institute

Phase 1 Completed
9 enrolled 17 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡